The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. The risk is increased with the use of cardiovascular disease-preventing therapies. Low-dose aspirin is defined as 75 to 325 mg.
Clinical Gastroenterology and Hepatology, Dec 2011